title: Comment: risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine.
authors.forename: Mong-Liang
authors.initials: ML
authors.lastname: Lu
authors.forename: Winston W
authors.initials: WW
authors.lastname: Shen
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects*; D001480:Basal Ganglia Diseases / Q000139:chemically induced*; D001569:Benzodiazepines; D004305:Dose-Response Relationship, Drug; D006220:Haloperidol / Q000009:adverse effects*; D006801:Humans; D000077152:Olanzapine; D010890:Pirenzepine / Q000009:adverse effects* / Q000031:analogs & derivatives*; D018967:Risperidone / Q000009:adverse effects*
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D006220:Haloperidol; D018967:Risperidone; D000077152:Olanzapine